Liquidia Corporation (LQDA)
NASDAQ: LQDA · Real-Time Price · USD
54.43
-2.20 (-3.88%)
At close: Nov 20, 2026, 4:00 PM EST
54.30
-0.13 (-0.24%)
After-hours: Nov 20, 2026, 7:57 PM EST
Liquidia Revenue
Liquidia had revenue of $225.30M in the quarter ending September 30, 2026, with 314.60% growth. This brings the company's total for the last twelve months to $621.87M, up 798.44% year-over-year. In the year 2025, Liquidia had annual revenue of $158.32M with 1,031.18% growth. That makes Liquidia the 10,054th largest company in the world by revenue and 2,158th in the United States.
Revenue (ttm)
$621.87M
Revenue Growth
+798.44%
P/S Ratio
7.89
Revenue / Employee
$2,879,005
Employees
216
Market Cap
4.90B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 158.32M | 144.32M | 1,031.18% |
| Dec 31, 2024 | 14.00M | -3.49M | -19.97% |
| Dec 31, 2023 | 17.49M | 1.55M | 9.75% |
| Dec 31, 2022 | 15.94M | 3.08M | 23.98% |
| Dec 31, 2021 | 12.85M | 12.11M | 1,637.77% |
| Dec 31, 2020 | 739.63K | -7.33M | -90.84% |
| Dec 31, 2019 | 8.07M | 5.37M | 198.20% |
| Dec 31, 2018 | 2.71M | -4.55M | -62.70% |
| Dec 31, 2017 | 7.26M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Bausch Health Companies | 11.11B |
| Amneal Pharmaceuticals | 3.20B |
| Hims & Hers Health | 2.87B |
| Alkermes | 1.75B |
| Lantheus Holdings | 1.56B |
| Supernus | 1.37B |
| Prestige Consumer Healthcare | 1.17B |
| Kiniksa Pharmaceuticals International, | 945.96M |
LQDA News
- 4 days ago - Liquidia Transcript: Jefferies Global Healthcare Conference - Transcripts
- 8 days ago - Liquidia assumed with a Buy at H.C. Wainwright - TheFly
- 10 days ago - Liquidia upgraded to Strong Buy from Outperform at Raymond James - TheFly
- 10 days ago - Liquidia upgraded to Strong Buy from Outperform at Raymond James - TheFly
- 10 days ago - Liquidia price target raised to $54 from $42 at BofA - TheFly
- 10 days ago - Liquidia price target raised to $40 from $33 at Wells Fargo - TheFly
- 11 days ago - Liquidia price target raised to $66 from $58 at Needham - TheFly
- 11 days ago - Liquidia price target raised to $62 from $55 at Jefferies - TheFly